- Home
- Publications
- Publication Search
- Publication Details
Title
Gene Therapy for Rheumatoid Arthritis
Authors
Keywords
-
Journal
BIODRUGS
Volume 25, Issue 6, Pages 381-391
Publisher
Springer Nature
Online
2011-11-04
DOI
10.2165/11595490-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
- (2010) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: The role of acute-phase reactants
- (2010) Josef S. Smolen et al. ARTHRITIS AND RHEUMATISM
- Getting arthritis gene therapy into the clinic
- (2010) Christopher H. Evans et al. Nature Reviews Rheumatology
- Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
- (2010) A. Rubbert-Roth et al. RHEUMATOLOGY
- In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance
- (2009) A. Annoni et al. BLOOD
- State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
- (2009) Katia Pauwels et al. CURRENT GENE THERAPY
- Clinical Responses to Gene Therapy in Joints of Two Subjects with Rheumatoid Arthritis
- (2009) Peter Wehling et al. HUMAN GENE THERAPY
- Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study
- (2009) P. J. MEASE et al. JOURNAL OF RHEUMATOLOGY
- Synovial fibroblasts spread rheumatoid arthritis to unaffected joints
- (2009) Stephanie Lefèvre et al. NATURE MEDICINE
- Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
- (2009) Brian D. Brown et al. NATURE REVIEWS GENETICS
- Gene therapy of the rheumatic diseases: 1998 to 2008
- (2009) Christopher H Evans et al. ARTHRITIS RESEARCH & THERAPY
- Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study
- (2008) P J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
- (2008) M Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Manufacturing and characterizing AAV-based vectors for use in clinical studies
- (2008) J F Wright GENE THERAPY
- Clinical gene therapy using recombinant adeno-associated virus vectors
- (2008) C Mueller et al. GENE THERAPY
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started